Tan Jie, Chen Jialiang
The First Clinical College of Hubei University of Chinese Medicine Wuhan 430061, Hubei, China.
Medical Laboratory Science of Hubei Provincial Hospital of TCM Wuhan 430061, Hubei, China.
Am J Transl Res. 2022 Feb 15;14(2):1068-1075. eCollection 2022.
To explore the correlation between abnormal changes in peripheral blood T lymphocyte subsets and disease progression in patients with active rheumatoid arthritis (RA).
This is a retrospective study, in which 53 patients with active RA were selected as the study subjects and 50 healthy people were selected as the control group. Lymphocyte subsets were determined in both arms. According to whether CD4/CD8 ratio increased, RA patients were subdivided into an elevated CD4/CD8 group and a non-elevated CD4/CD8 group, and compared to the control group. The risk factors affecting the disease progression of patients with active RA were analyzed.
CD4 T lymphocyte subsets in patients with increased CD4/CD8 were significantly higher than those in healthy controls. In addition, the elevated CD4/CD8 group showed significantly CD8 T lymphocyte subsets than the non-elevated CD4/CD8 group and the control group (P<0.05). The CD4 T lymphocyte subsets in the elevated CD4/CD8 group were not significantly higher than those in the non-elevated CD4/CD8 group (P>0.05). The CD3 T lymphocyte subsets as well as CD19 B and NK lymphocyte subsets showed no significant difference among the three arms (P>0.05). In addition, CD4, CD8 and CD4/CD8 were identified to be the risk factors affecting disease progression in patients with active RA.
When an autoimmune disorder occurs in patients with active RA, CD8 T lymphocyte subsets are significantly suppressed, while CD4 T lymphocyte subsets show different manifestations, with some patients presenting no obvious increase. In addition, CD4, CD8 and CD4/CD8 can help to indicate the risk of disease progression in patients with active RA.
探讨活动期类风湿关节炎(RA)患者外周血T淋巴细胞亚群异常变化与疾病进展的相关性。
本研究为回顾性研究,选取53例活动期RA患者作为研究对象,选取50例健康人作为对照组。检测两组的淋巴细胞亚群。根据CD4/CD8比值是否升高,将RA患者分为CD4/CD8升高组和CD4/CD8未升高组,并与对照组进行比较。分析影响活动期RA患者疾病进展的危险因素。
CD4/CD8升高患者的CD4 T淋巴细胞亚群显著高于健康对照组。此外,CD4/CD8升高组的CD8 T淋巴细胞亚群显著低于CD4/CD8未升高组和对照组(P<0.05)。CD4/CD8升高组的CD4 T淋巴细胞亚群与CD4/CD8未升高组相比无显著差异(P>0.05)。三组间CD3 T淋巴细胞亚群以及CD19 B和NK淋巴细胞亚群无显著差异(P>0.05)。此外,CD4、CD8和CD4/CD8被确定为影响活动期RA患者疾病进展的危险因素。
活动期RA患者发生自身免疫紊乱时,CD8 T淋巴细胞亚群显著受抑,而CD4 T淋巴细胞亚群表现各异,部分患者无明显升高。此外,CD4、CD8和CD4/CD8有助于提示活动期RA患者的疾病进展风险。